000 01281 a2200361 4500
005 20250516163209.0
264 0 _c20131122
008 201311s 0 0 fre d
022 _a1769-6917
024 7 _a10.1684/bdc.2013.1800
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTougeron, David
245 0 0 _a[Immunotherapy for colorectal cancer].
_h[electronic resource]
260 _bBulletin du cancer
_cSep 2013
300 _a871-85 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntigens, Neoplasm
_ximmunology
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aColorectal Neoplasms
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunity, Cellular
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aImmunotherapy, Adoptive
_xmethods
650 0 4 _aPrognosis
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aFauquembergue, Émilie
700 1 _aLatouche, Jean-Baptiste
773 0 _tBulletin du cancer
_gvol. 100
_gno. 9
_gp. 871-85
856 4 0 _uhttps://doi.org/10.1684/bdc.2013.1800
_zAvailable from publisher's website
999 _c22977956
_d22977956